Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Baxter International Inc's Business Segments
Baxter International Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
4
Largest Segment
Medical Products and Therapies
Total Revenue
$ 2,701
Regions Reported
1
Revenue Share by Reportable Segment - Q1 FY2026
- Medical Products and Therapies47.6%
- Healthcare Systems and Technologies26.1%
- Pharmaceuticals23%
- Corporate and Unallocated3.3%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Medical Products and Therapies | $ 1,285 | 47.6% |
| Healthcare Systems and Technologies | $ 705 | 26.1% |
| Pharmaceuticals | $ 621 | 23% |
1 more segments available
Sign in to unlock the full Baxter International Inc dataset.
Revenue Share by Region - Q1 FY2026
- Non-US1.4%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Non-US | $ 39 | 1.4% |
Revenue by Product & Service Category - Q1 FY2026
- Infusion Therapies and Technologies36.3%
- Care and Connectivity Solutions16.1%
- Pharmaceutical Compounding11.8%
- Advanced Surgery11.3%
- Injectables and Anesthesia11.1%
- Front Line Care10%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Infusion Therapies and Technologies | $ 981 | 36.3% |
| Care and Connectivity Solutions | $ 435 | 16.1% |
| Pharmaceutical Compounding | $ 320 | 11.8% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Baxter International Inc dataset.
Description of Baxter International Inc
Baxter International Inc. is an American healthcare products company that specializes in the development and manufacturing of products for the treatment of a wide range of medical conditions. Founded in 1931 and headquartered in Deerfield, Illinois, Baxter has grown to become a global leader in the healthcare industry.
Baxter operates through two main segments: Hospital Products and Renal Products. The Hospital Products segment offers intravenous (IV) solutions, drug reconstitution systems, and premixed drugs in flexible containers, as well as anesthesia and critical care products. These products are used in hospitals, clinics, and other healthcare facilities for various applications such as surgical procedures, drug administration, and patient monitoring.
The Renal Products segment focuses on products and services for patients with kidney failure. Baxter manufactures and sells dialysis machines, dialyzers, bloodlines, and other supplies required for hemodialysis and peritoneal dialysis treatments. In addition, the company provides clinical support and services to assist healthcare professionals in managing and treating kidney disease.
Beyond these two main segments, Baxter also offers a range of nutritional therapies, including parenteral nutrition, which provides essential nutrients to patients who are unable to obtain them through oral consumption. The company's nutritional therapies division also provides specialized enteral nutrition formulas for individuals with specific dietary needs.
Furthermore, Baxter has a biosurgery segment that focuses on advanced surgical products for hemostasis (controlling bleeding), tissue sealing, and reconstruction. These products are used by surgeons to manage bleeding in various surgical procedures, promote tissue regeneration, and improve patient outcomes.
Baxter's commitment to innovation is a key driving force behind its success. The company invests heavily in research and development to continuously develop and improve its products. Baxter also actively seeks strategic partnerships and collaborations with other healthcare companies and institutions to leverage expertise and resources in order to bring innovative solutions to market.
In addition to its product offerings, Baxter places a strong emphasis on sustainability and corporate social responsibility. The company has set ambitious environmental goals to reduce its greenhouse gas emissions, water consumption, and waste generation. Baxter also actively supports communities through philanthropic initiatives such as employee volunteer programs and charitable donations.
Overall, Baxter International Inc. is a global healthcare products company that is dedicated to improving patients' lives through the development and manufacturing of innovative medical solutions. With a diverse portfolio of products and a strong focus on sustainability, Baxter continues to be a leader in the healthcare industry.
Baxter operates through two main segments: Hospital Products and Renal Products. The Hospital Products segment offers intravenous (IV) solutions, drug reconstitution systems, and premixed drugs in flexible containers, as well as anesthesia and critical care products. These products are used in hospitals, clinics, and other healthcare facilities for various applications such as surgical procedures, drug administration, and patient monitoring.
The Renal Products segment focuses on products and services for patients with kidney failure. Baxter manufactures and sells dialysis machines, dialyzers, bloodlines, and other supplies required for hemodialysis and peritoneal dialysis treatments. In addition, the company provides clinical support and services to assist healthcare professionals in managing and treating kidney disease.
Beyond these two main segments, Baxter also offers a range of nutritional therapies, including parenteral nutrition, which provides essential nutrients to patients who are unable to obtain them through oral consumption. The company's nutritional therapies division also provides specialized enteral nutrition formulas for individuals with specific dietary needs.
Furthermore, Baxter has a biosurgery segment that focuses on advanced surgical products for hemostasis (controlling bleeding), tissue sealing, and reconstruction. These products are used by surgeons to manage bleeding in various surgical procedures, promote tissue regeneration, and improve patient outcomes.
Baxter's commitment to innovation is a key driving force behind its success. The company invests heavily in research and development to continuously develop and improve its products. Baxter also actively seeks strategic partnerships and collaborations with other healthcare companies and institutions to leverage expertise and resources in order to bring innovative solutions to market.
In addition to its product offerings, Baxter places a strong emphasis on sustainability and corporate social responsibility. The company has set ambitious environmental goals to reduce its greenhouse gas emissions, water consumption, and waste generation. Baxter also actively supports communities through philanthropic initiatives such as employee volunteer programs and charitable donations.
Overall, Baxter International Inc. is a global healthcare products company that is dedicated to improving patients' lives through the development and manufacturing of innovative medical solutions. With a diverse portfolio of products and a strong focus on sustainability, Baxter continues to be a leader in the healthcare industry.
Baxter International Inc. is a global healthcare company that provides a diverse range of products and services primarily focused on therapies for individuals with complex medical conditions, including those with chronic illnesses. Baxter operates in multiple segments, and each segment is associated with a variety of products and services aimed at addressing a wide range of healthcare needs.
Segments and Offerings
1. Renal Care
Baxter is a major player in the renal care market, providing solutions for patients with chronic kidney disease and those requiring dialysis treatment. The products and services offered include:
- Peritoneal Dialysis (PD): Baxter offers a range of PD solutions, including dialysis machines and consumables that facilitate home therapy, allowing patients to manage their treatment in their own environments.
- Hemodialysis: The company provides a suite of hemodialysis products, including machines and dialyzers, which are used in both acute and chronic settings.
- Renal Pharmaceuticals: Baxter also has a portfolio of pharmaceuticals designed to manage secondary conditions associated with renal failure, like anemia and minerals and bone disorder treatments.
Hospital Products
This segment encompasses products and services that support healthcare providers in hospitals and clinics, focusing on improving patient outcomes. Key offerings include:
- Intravenous (IV) Solutions: Baxter produces a wide array of IV solutions for hydration, electrolyte replenishment, and nutrition.
- IV Administration and Infusion Systems: The company has developed advanced infusion devices that enhance medication delivery, including smart pumps and equipment that improve safety and efficiency in medication administration.
- Surgical Products: Baxter offers products that support various surgical procedures, including hemostatic agents, surgical mesh, and other related surgical offerings.
- Anaesthesia Products: The company provides a line of products that support anesthesia delivery and monitoring, ensuring patient safety during surgical procedures.
BioScience
The BioScience segment focuses on providing therapeutics that are primarily derived from blood plasma or recombinantly produced. Offerings include:
- Hemophilia Products: Baxter is one of the leading providers of factor replacement therapies used to treat hemophilia A and B, featuring various recombinant clotting factors.
- Immunoglobulin Products: These are used to treat immune deficiencies and autoimmune disorders. Baxter offers both intravenous and subcutaneous immunoglobulin therapies.
- Albumin and Clotting Factors: The company manufactures albumin for critical care and various blood-based clotting factors for patients with bleeding disorders.
Advanced Surgery
Under this segment, Baxter supplies products that cater specifically to the needs of surgical professionals and patients. Key offerings include:
- Surgical Sealants and Adhesives: These medical devices are utilized to facilitate wound closure and minimize bleeding during surgeries.
- Tissue Management Products: Baxter provides a range of bio-surgical products that enhance tissue regeneration and healing.
- Interventional Products: This includes devices used in minimally invasive procedures aimed at enhancing surgical precision and patient care.
Medication Delivery
This segment focuses on safety and efficiency in delivering medications across various settings.
- Smart Infusion Pumps: Advanced technologies for medication delivery that enable dose calculation and monitoring.
- Syringe and IV Bag Systems: Baxter develops and distributes a range of drug delivery systems that improve the safety and reliability of medication administration.
- Controlled Substances: The company offers secure medication management systems for controlled substances, ensuring compliance with regulatory standards.
Services
In addition to tangible products, Baxter provides a range of value-added services to enhance the healthcare experience:
- Patient Support Programs: Tailored initiatives that assist patients in navigating treatment options, medication adherence, and managing chronic conditions effectively.
- Training and Education: Baxter offers comprehensive training programs for healthcare professionals to ensure safe and effective use of their products.
- Supply Chain Solutions: The company provides logistics and management services to help healthcare facilities optimize their inventory and distribution of Baxter products.
Conclusion
Baxter International Inc. demonstrates a robust commitment to meeting the complexities of modern healthcare through its comprehensive portfolio spanning renal care, hospital products, biologic therapies, surgical solutions, and medication delivery systems. Through its products and services, the company aims to improve clinical outcomes and enhance the lives of patients worldwide, aligning closely with the evolving needs of the healthcare industry.
Segments and Offerings
1. Renal Care
Baxter is a major player in the renal care market, providing solutions for patients with chronic kidney disease and those requiring dialysis treatment. The products and services offered include:
- Peritoneal Dialysis (PD): Baxter offers a range of PD solutions, including dialysis machines and consumables that facilitate home therapy, allowing patients to manage their treatment in their own environments.
- Hemodialysis: The company provides a suite of hemodialysis products, including machines and dialyzers, which are used in both acute and chronic settings.
- Renal Pharmaceuticals: Baxter also has a portfolio of pharmaceuticals designed to manage secondary conditions associated with renal failure, like anemia and minerals and bone disorder treatments.
Hospital Products
This segment encompasses products and services that support healthcare providers in hospitals and clinics, focusing on improving patient outcomes. Key offerings include:
- Intravenous (IV) Solutions: Baxter produces a wide array of IV solutions for hydration, electrolyte replenishment, and nutrition.
- IV Administration and Infusion Systems: The company has developed advanced infusion devices that enhance medication delivery, including smart pumps and equipment that improve safety and efficiency in medication administration.
- Surgical Products: Baxter offers products that support various surgical procedures, including hemostatic agents, surgical mesh, and other related surgical offerings.
- Anaesthesia Products: The company provides a line of products that support anesthesia delivery and monitoring, ensuring patient safety during surgical procedures.
BioScience
The BioScience segment focuses on providing therapeutics that are primarily derived from blood plasma or recombinantly produced. Offerings include:
- Hemophilia Products: Baxter is one of the leading providers of factor replacement therapies used to treat hemophilia A and B, featuring various recombinant clotting factors.
- Immunoglobulin Products: These are used to treat immune deficiencies and autoimmune disorders. Baxter offers both intravenous and subcutaneous immunoglobulin therapies.
- Albumin and Clotting Factors: The company manufactures albumin for critical care and various blood-based clotting factors for patients with bleeding disorders.
Advanced Surgery
Under this segment, Baxter supplies products that cater specifically to the needs of surgical professionals and patients. Key offerings include:
- Surgical Sealants and Adhesives: These medical devices are utilized to facilitate wound closure and minimize bleeding during surgeries.
- Tissue Management Products: Baxter provides a range of bio-surgical products that enhance tissue regeneration and healing.
- Interventional Products: This includes devices used in minimally invasive procedures aimed at enhancing surgical precision and patient care.
Medication Delivery
This segment focuses on safety and efficiency in delivering medications across various settings.
- Smart Infusion Pumps: Advanced technologies for medication delivery that enable dose calculation and monitoring.
- Syringe and IV Bag Systems: Baxter develops and distributes a range of drug delivery systems that improve the safety and reliability of medication administration.
- Controlled Substances: The company offers secure medication management systems for controlled substances, ensuring compliance with regulatory standards.
Services
In addition to tangible products, Baxter provides a range of value-added services to enhance the healthcare experience:
- Patient Support Programs: Tailored initiatives that assist patients in navigating treatment options, medication adherence, and managing chronic conditions effectively.
- Training and Education: Baxter offers comprehensive training programs for healthcare professionals to ensure safe and effective use of their products.
- Supply Chain Solutions: The company provides logistics and management services to help healthcare facilities optimize their inventory and distribution of Baxter products.
Conclusion
Baxter International Inc. demonstrates a robust commitment to meeting the complexities of modern healthcare through its comprehensive portfolio spanning renal care, hospital products, biologic therapies, surgical solutions, and medication delivery systems. Through its products and services, the company aims to improve clinical outcomes and enhance the lives of patients worldwide, aligning closely with the evolving needs of the healthcare industry.